Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer

Korkmaz, Elif; KÖKSAL, DENİZ; Aksu, Funda; DİKMEN, ZELİHA; İÇEN, DUYGU; Maden, Emin; Onder, Sevgen; Akbiyik, FİLİZ; Emri, Salih

doi:10.1016/j.clinbiochem.2018.05.001

Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer

Atıf İçin Kopyala

Korkmaz E. T., KÖKSAL D., Aksu F., DİKMEN Z. G., İÇEN D., Maden E., ...Daha Fazla

CLINICAL BIOCHEMISTRY, cilt.58, ss.15-19, 2018 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 58
Basım Tarihi: 2018
Doi Numarası: 10.1016/j.clinbiochem.2018.05.001
Dergi Adı: CLINICAL BIOCHEMISTRY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.15-19
Hacettepe Üniversitesi Adresli: Evet

Özet

Background and aim: Early diagnosis and histological subtyping are important issues in the management of patients with lung cancer (LC). The aim of this study is to investigate the diagnostic value of a panel of serum tumor markers in newly diagnosed patients with LC.